Circulating miR-15a and miR-222 as Potential Biomarkers of Type 2 Diabetes.
Salman SadeghzadehMahmood Dehghani AshkezariSeyed Morteza SeifatiMohammad Yahya Vahidi MehrjardiMasoud Dehghan TezerjaniSara SadeghzadehSeyed Amir Behtash LadanPublished in: Diabetes, metabolic syndrome and obesity : targets and therapy (2020)
This study indicated that the plasma expression levels of miR-222 and miR-15a can be considered as non-invasive, fast tools to separate the pre-T2D individuals from their healthy counterparts. Accordingly, this information could be used to predict the development of the disease as well as a direction for optimal therapy, thus refining outcomes in patients with diabetes.